Markets Stocks Economy Crypto Earnings Banking Energy
Home Stocks Feature
Stocks · Exclusive

RBC sees more upside in Martin Marietta's lime deal than market prices

RBC sees more upside in Martin Marietta's lime deal than market prices
Stocks · 2026
Photo · Eleanor Whitfield for Daily Digest Invest
By Eleanor Whitfield Markets Editor-in-Chief Aug 28, 2026 4 min read

RBC Capital Markets believes Martin Marietta Materials' just-completed acquisition of Lhoist North America could add more to the company's bottom line than the market is currently giving it credit for. Even with the stock trading near $527, the investment bank argues the deal is more transformative than the share price suggests.

Martin Marietta, a major U.S. supplier of building materials, finalized its purchase of Lhoist North America, a producer of lime and other industrial minerals. RBC called the deal "transformational" because it shifts the company's business mix toward lime, which the bank says offers steadier demand and stronger pricing power than traditional aggregates like crushed stone and gravel.

Why lime is a different business

Lime, a versatile mineral used in steelmaking, water treatment, and construction, is often sold under longer-term contracts. That means revenue is more predictable than in the aggregates business, where sales can swing with the pace of housing starts and infrastructure spending. RBC's view is that this contracted demand gives Martin Marietta better visibility into future cash flows and more ability to raise prices without losing customers.

The bank also highlighted that the market may be overlooking more than $150 million in potential synergies from the deal. Synergies are the cost savings or revenue boosts that come from combining two companies—things like eliminating duplicate back-office functions, streamlining logistics, or cross-selling products to existing customers. When a company pays a premium to acquire another, investors often worry about whether those savings will actually materialize. RBC's estimate suggests the upside could be larger than the current stock price reflects.

What RBC changed in its forecasts

As a result, RBC raised its revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) estimates for Martin Marietta for 2026 and 2027. EBITDA is a common measure of a company's operating profitability, stripping out the effects of financing and accounting decisions. The upward revision signals that RBC expects the deal to contribute more to earnings than previously modeled.

This is not the first time RBC has adjusted forecasts for a company after a major move. In other sectors, analysts have similarly revised outlooks when they saw hidden potential in a deal. For instance, NEXTDC beat RBC forecasts after its contracted EBITDA topped AU$1 billion, showing how analyst revisions can sometimes lag reality.

What it means for investors

For everyday investors, this is a reminder that analyst upgrades and downgrades can move stock prices, but they are not a guarantee of future performance. RBC's optimism is based on its own analysis of the deal's potential, but other banks or the market as a whole may see things differently. The stock's current price already reflects a lot of good news, so the question is whether the synergies will be as large as RBC expects.

Investors should also consider that acquisitions often carry integration risks. Combining two companies can be complex, and expected synergies sometimes fail to materialize on schedule. Even if the deal is strategically sound, execution matters. Martin Marietta will need to successfully fold Lhoist North America into its operations, retain key customers, and achieve the cost savings RBC is counting on.

Another angle: the broader construction and infrastructure market. Martin Marietta's core aggregates business is tied to public works projects and private construction. If those sectors slow, the lime business could provide a buffer, given its contracted revenue. That diversification is part of why RBC sees the deal as transformative.

For those watching the stock, the key metrics to track will be quarterly earnings reports over the next couple of years. If Martin Marietta starts reporting revenue and EBITDA that beat analyst estimates, that would support RBC's thesis. If it falls short, the market may have been right to be cautious.

In the meantime, investors can look at other examples where analysts saw hidden value. For instance, Morgan Stanley lifted its Nvidia revenue view for 2028, seeing 70% growth, a similar pattern of analysts being more bullish than the market. And Best Buy beat Q2 estimates and raised its 2027 profit outlook, showing how companies can surprise to the upside.

Ultimately, RBC's move is a positive signal, but it's not a buy recommendation. It's an analyst's opinion, and investors should do their own research or consult a financial advisor before making decisions. The takeaway is that Martin Marietta's lime deal could be a bigger deal than the market thinks, but only time will tell if the synergies materialize.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B